Tirzepatide: Dual GIP/GLP-1 Receptor Agonist Tirzepatide activates two receptor types simultaneously: GLP-1: Same appetite suppression and insulin-stimulating benefits as semaglutide GIP (Glucose-dependent insulinotropic polypeptide): Improves insulin sensitivity, influences fat metabolism, and may change how the body responds to nutrient intake GIP receptor activation is what sets tirzepatide apart
If you experience unexpected side effects or injection site reactions, seek advice from a healthcare professional promptly
For example, over 72 weeks, people taking the highest maintenance dose of Mounjaro can lose up to 22.5% of their starting body weight, whereas people on the highest Wegovy maintenance dose can lose up to 21% of their body weight in 72 weeks
Understanding Semaglutide Before You Begin Semaglutide is a GLP-1 receptor agonist a medication that mimics glucagon-like peptide-1, a hormone naturally produced in the gut after eating
5mL vialTesamorelin 15mg + Ipamorelin 10mg 1
Not Sure How Your Metabolism Is Working